Bloodstream Infections in Patients With Rheumatoid Arthritis

Incidence and Risk Factors of Staphylococcus Aureus Bacteremia in Patients With Rheumatoid Arthritis Compared With the General Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03908086

Enrollment

6000000

Registered

2019-04-09

Start date

1996-12-31

Completion date

2017-12-31

Last updated

2019-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis, Staphylococcus Aureus Bacteremia

Brief summary

Study of incidence and risk factors of staphylococcus aureus bacteremia in patients with rheumatoid arthritis compared with the general population in a nationwide cohort of all adult members of the population from 1996 until 2017 using national registries

Interventions

OTHERRisk factors in RA cohort

OTHERRisk factors in general population

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* All members of the adult Danish population

Exclusion criteria

* Staphylococcus aureus bacteremia prior to inclusion. * Rheumatoid arthritis diagnosed prior to inclusion.

Design outcomes

Primary

Measure	Time frame	Description
Incidence of staphylococcus aureus bacteremia	0-21 years	—
Incidence rate ratios	0-21 years	Comparing rheumatoid arthritis patients with the general population

Secondary

Measure	Time frame	Description
Risk factors of staphylococcus aureus bacteremia	0-21 years	Identification of risk factors both universal to both the general population and rheumatoid arthritis (RA) cohorts and RA disease specific factors (disease duration, disease activity, smoking, joint erosions, etc.)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026